Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reaction of cytochrome bo3 with oxygen: extra redox center(s) are present in the protein.

Biochemistry·1995
Same author

Regulation of striatal cyclic-3',5'-adenosine monophosphate accumulation and GABA release by glutamate metabotropic and dopamine D1 receptors.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Calculation of relative binding free energies and configurational entropies: a structural and thermodynamic analysis of the nature of non-polar binding of thrombin inhibitors based on hirudin55-65.

Journal of molecular biology·1995
Same author

Hydroxylated aromatic inhibitors of HIV-1 integrase.

Journal of medicinal chemistry·1995
Same author

Sevoflurane for outpatient anesthesia: a comparison with propofol.

Anesthesia and analgesia·1995
Same author

Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells.

Immunity·1995

Related Experiment Video

Updated: May 26, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Using feature selection technique for drug-target interaction networks prediction.

W Yu1, Z Jiang, J Wang

  • 1Department of Computer Science & Technology, East China Normal University, Shanghai, 200241, PR China.

Current Medicinal Chemistry
|December 17, 2011
PubMed
Summary

This study introduces a new method to predict drug-target interactions by optimizing feature selection and using an improved bipartite learning graph. The approach enhances the discovery of novel drug targets and improves prediction accuracy.

Related Experiment Videos

Last Updated: May 26, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Understanding drug-target interactions is crucial for identifying new drug targets.
  • Integrating diverse feature information for drug-target interaction prediction presents a significant challenge.
  • Existing methods struggle to create a unified 'knowledge view' for accurate prediction.

Purpose of the Study:

  • To develop an effective feature selection method for optimizing drug-target interaction prediction.
  • To propose an improved bipartite learning graph approach for predicting drug-target relationships.
  • To enhance the accuracy and reliability of drug-target interaction predictions.

Main Methods:

  • A novel feature selection technique was employed to rank and select optimal feature subsets.
  • An improved bipartite learning graph algorithm was utilized for predicting drug-target interactions.
  • The proposed method was evaluated on four diverse drug-target datasets using cross-validation.

Main Results:

  • The feature selection method effectively ranked and optimized original feature sets.
  • The improved bipartite learning graph demonstrated superior performance in predicting drug-target interactions.
  • The method achieved better results compared to previous approaches across four drug target families.

Conclusions:

  • The proposed integrated approach, combining feature selection and bipartite learning, significantly improves drug-target interaction prediction.
  • This method offers a more robust framework for discovering novel drug targets.
  • The findings suggest a promising direction for advancing computational drug discovery.